Z. Rahmat, M. H. Ali, Muhammad Talha, Md. Al Hasibuzzaman
{"title":"FDA approval of casgevy and lyfgenia: A dual breakthrough in gene therapies for sickle cell disease","authors":"Z. Rahmat, M. H. Ali, Muhammad Talha, Md. Al Hasibuzzaman","doi":"10.1097/ms9.0000000000002409","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":503882,"journal":{"name":"Annals of Medicine & Surgery","volume":"38 19","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Medicine & Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ms9.0000000000002409","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
